Karen Curtin, Ph.D., M.Stat

Research Interests

  • Environmental Pollution
  • Epigenetics in Cancer
  • Gene-Environment Interaction
  • Age-related macular degeneration and co-segregating diseases
  • Cancer Epidemiology with Emphasis on Colorectal Cancer

Languages

  • English
  • Greek
  • Spanish

Academic Information

  • Departments: Family and Preventive Medicine - Adjunct Associate Professor, Internal Medicine - Research Associate Professor, Ophthalmology/Visual Sciences - Adjunct Associate Professor
  • Divisions: Genetic Epidemiology, Public Health
  • Cancer Center Programs: Cancer Control & Population Sciences

Academic Office Information

  • (801) 585-5320
  • Pedigree and Population Resource
    Utah Population Database, University of Utah & Huntsman Cancer Institute
    675 Arapeen Drive, Room: 210 (Suite 200)
    Salt Lake City, UT 84112

Academic Bio

Karen Curtin (PhD, MStat) is an associate research professor in the Department of Medicine (Division of Genetic Epidemiology) and an adjunct associate professor in the Department of Ophthalmology and Visual Sciences at the University of Utah School of Medicine and the John A. Moran Eye Center, Sharon Eccles Steele Center for Translational Medicine. She serves as Associate Director of Pedigree & Population Resource at the Huntsman Cancer Institute, the group that administers the Utah Population Database (the UPDB). In this capacity, she collaborates as a genetic and risk factor epidemiologist with investigators across the Health Sciences Center in addition to pursuing her own research interests. Dr. Curtin is a Huntsman Cancer Institute investigator and member of the Cancer Control and Population Sciences program, with a keen interest in the interaction of environmental, lifestyle, and genetic risk factors in the development of common, complex disease using unique research resources available in the state of Utah.

Her wide array of research interests and experience in research infrastructure and project development have resulted in cross-disciplinary collaborations that include an investigation partnering with the College of Pharmacy and Intermountain Healthcare clinicians to investigate a statewide cohort of amphetamine-type stimulant users to examine the incidence of Parkinson's disease. She is undertaking a study to use electronic databases to identify a subset of colorectal adenomas (sessile serrated polyps), of which little is known at the population level. It is thought these lesions are associated with missed or ‘interval’ cancers, but studies to date have been small, clinic-based investigations. She is currently funded to investigate novel areas of mammographic breast density in relation to breast cancer, the familiality breast density in a large Utah cohort of women and the association of tamoxifen treatment with breast density and breast cancer recurrence and metastatic progression. The research directly relates to cancer prevention by potentially informing screening recommendations and may provide further evidence of the role of genetics in breast density, a known risk factor for breast cancer and will utilize UPDB information linked to University and Intermountain records including complex radiology and pharmacy data.

Curtin received her PhD in biomedical informatics with an emphasis in genetic epidemiology from the University of Utah. She received post-doctoral training in molecular, genetic, and risk factor epidemiology of cancer at the University of Utah. Prior to receiving her PhD, she was a Masters level biostatistician on large externally-funded cancer studies. She received the 2008 John D. Morgan Fellowship Award in Biomedical Informatics at the University of Utah. A prolific and extensively published researcher, she recently received recognition from Cancer Epidemiology, Biomarkers & Prevention, a high-impact peer-reviewed journal, for one of the 20 most frequently cited articles of 2009. Dr. Curtin is a member of the American Society of Human Genetics, the American Association for Cancer Research and the International Genetic Epidemiology Society.

Education History

Type School Degree
Doctoral Training University of Utah School of Medicine, Clinical and Translational Track: Genetic Epidemiology
Biomedical Informatics
Ph.D.
Graduate Training University of Utah, College of Social and Behavioral Sciences
Econometrics and Statistics
M.Stat
Undergraduate University of Utah, College of Business
Economics, Magna Cum Laude
B.S.

Selected Publications

Journal Article

  1. Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.LID - 10.1007/s10620-016-4435-4 [doi]Jewel Samadder N, Valentine JF, Guthery S, Singh H, Bernstein CN, Wan Y, Wong J, Boucher K, Pappas L, Rowe K, Bronner M, Ulrich CM, Burt RW, Curtin K, Smith KR (2017). Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.LID - 10.1007/s10620-016-4435-4 [doi]. (Epub ahead of print) Dig Dis Sci.
  2. Risk for Exfoliation Syndrome in Women With Pelvic Organ Prolapse : A Utah Project on Exfoliation Syndrome (UPEXS) Study.Wirostko BM, Curtin K, Ritch R, Thomas S, Allen-Brady K, Smith KR, Hageman GS, Allingham RR (2016). Risk for Exfoliation Syndrome in Women With Pelvic Organ Prolapse : A Utah Project on Exfoliation Syndrome (UPEXS) Study. JAMA Ophthalmol, 134(11), 1255-1262.
  3. A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.Rand KA, Song C, Dean E, Serie DJ, Curtin K, Sheng X, Hu D, Huff CA, Bernal-Mizrachi L, Tomasson MH, Ailawadhi S, Singhal S, Pawlish K, Peters ES, Bock CH, Stram A, Van Den Berg DJ, Edlund CK, Conti DV, Zimmerman T, Hwang AE, Huntsman S, Graff J, Nooka A, Kong Y, Pregja SL, Berndt SI, Blot WJ, Carpten J, Casey G, Chu L, Diver WR, Stevens VL, Lieber MR, Goodman PJ, Hennis AJ, Hsing AW, Mehta J, Kittles RA, Kolb S, Klein EA, Leske C, Murphy AB, Nemesure B, Neslund-Dudas C, Strom SS, Vij R, Rybicki BA, Stanford JL, Signorello LB, Witte JS, Ambrosone CB, Bhatti P, John EM, Bernstein L, Zheng W, Olshan AF, Hu JJ, Ziegler RG, Nyante SJ, Bandera EV, Birmann BM, Ingles SA, Press MF, Atanackovic D, Glenn MJ, Cannon-Albright LA, Jones B, Tricot G, Martin TG, Kumar SK, Wolf JL, Deming Halverson SL, Rothman N, Brooks-Wilson AR, Rajkumar SV, Kolonel LN, Chanock SJ, Slager SL, Severson RK, Janakiraman N, Terebelo HR, Brown EE, De Roos AJ, Mohrbacher AF, Colditz GA, Giles GG, Spinelli JJ, Chiu BC, Munshi NC, Anderson KC, Levy J, Zonder JA, Orlowski RZ, Lonial S, Camp NJ, Vachon CM, Ziv E, Stram DO, Hazelett DJ, Haiman CA, Cozen W (2016). A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci. Cancer Epidemiol Biomarkers Prev, 25(12), 1609-1618.
  4. Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah.Samadder NJ, Smith KR, Wong J, Hanson H, Boucher K, Burt RW, Charlton M, Byrne KR, Gallegos-Orozco JF, Koptiuch C, Curtin K (2016). Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah. Dig Dis Sci, 61(12), 3627-3632.
  5. Familial link of otitis media requiring tympanostomy tubes.LID - 10.1002/lary.26360 [doi]Padia R, Alt JA, Curtin K, Muntz HR, Orlandi RR, Berger J, Meier JD (2016). Familial link of otitis media requiring tympanostomy tubes.LID - 10.1002/lary.26360 [doi]. (Epub ahead of print) Laryngoscope.
  6. Evidence for a heritable contribution to neuroendocrine tumors of the small intestine.Neklason DW, VanDerslice J, Curtin K, Cannon-Albright LA (2016). Evidence for a heritable contribution to neuroendocrine tumors of the small intestine. Endocr Relat Cancer, 23(2), 93-100.
  7. Familial Risk in Patients With Carcinoma of Unknown Primary.Samadder NJ, Smith KR, Hanson H, Pimentel R, Wong J, Boucher K, Akerley W, Gilcrease G, Ulrich CM, Burt RW, Curtin K (2016). Familial Risk in Patients With Carcinoma of Unknown Primary. JAMA Oncol, 2(3), 340-6.
  8. Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.Berndt SI, Camp NJ, Skibola CF, Vijai J, Wang Z, Gu J, Nieters A, Kelly RS, Smedby KE, Monnereau A, Cozen W, Cox A, Wang SS, Lan Q, Teras LR, Machado M, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Vajdic CM, Cocco P, Zhang Y, Giles GG, Zeleniuch-Jacquotte A, Lawrence C, Montalvan R, Burdett L, Hutchinson A, Ye Y, Call TG, Shanafelt TD, Novak AJ, Kay NE, Liebow M, Cunningham JM, Allmer C, Hjalgrim H, Adami HO, Melbye M, Glimelius B, Chang ET, Glenn M, Curtin K, Cannon-Albright LA, Diver WR, Link BK, Weiner GJ, Conde L, Bracci PM, Riby J, Arnett DK, Zhi D, Leach JM, Holly EA, Jackson RD, Tinker LF, Benavente Y, Sala N, Casabonne D, Becker N, Boffetta P, Brennan P, Foretova L, Maynadie M, McKay J, Staines A, Chaffee KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Leis JF, Weinberg JB, Caporaso NE, Norman AD, De Roos AJ, Morton LM, Severson RK, Riboli E, Vineis P, Kaaks R, Masala G, Weiderpass E, Chirlaque MD, Vermeulen RC, Travis RC, Southey MC, Milne RL, Albanes D, Virtamo J, Weinstein S, Clavel J, Zheng T, Holford TR, Villano DJ, Maria A, Spinelli JJ, Gascoyne RD, Connors JM, Bertrand KA, Giovannucci E, Kraft P, Kricker A, Turner J, Ennas MG, Ferri GM, Miligi L, Liang L, Ma B, Huang J, Crouch S, Park JH, Chatterjee N, North KE, Snowden JA, Wright J, Fraumeni JF, Offit K, Wu X, de Sanjose S, Cerhan JR, Chanock SJ, Rothman N, Slager SL (2016). Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia. Nat Commun, 7, 10933.
  9. Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes.Machiela MJ, Lan Q, Slager SL, Vermeulen RC, Teras LR, Camp NJ, Cerhan JR, Spinelli JJ, Wang SS, Nieters A, Vijai J, Yeager M, Wang Z, Ghesquieres H, McKay J, Conde L, de Bakker PI, Cox DG, Burdett L, Monnereau A, Flowers CR, De Roos AJ, Brooks-Wilson AR, Giles GG, Melbye M, Gu J, Jackson RD, Kane E, Purdue MP, Vajdic CM, Albanes D, Kelly RS, Zucca M, Bertrand KA, Zeleniuch-Jacquotte A, Lawrence C, Hutchinson A, Zhi D, Habermann TM, Link BK, Novak AJ, Dogan A, Asmann YW, Liebow M, Thompson CA, Ansell SM, Witzig TE, Tilly H, Haioun C, Molina TJ, Hjalgrim H, Glimelius B, Adami HO, Roos G, Bracci PM, Riby J, Smith MT, Holly EA, Cozen W, Hartge P, Morton LM, Severson RK, Tinker LF, North KE, Becker N, Benavente Y, Boffetta P, Brennan P, Foretova L, Maynadie M, Staines A, Lightfoot T, Crouch S, Smith A, Roman E, Diver WR, Offit K, Zelenetz A, Klein RJ, Villano DJ, Zheng T, Zhang Y, Holford TR, Turner J, Southey MC, Clavel J, Virtamo J, Weinstein S, Riboli E, Vineis P, Kaaks R, Boeing H, Tjonneland A, Angelucci E, Di Lollo S, Rais M, De Vivo I, Giovannucci E, Kraft P, Huang J, Ma B, Ye Y, Chiu BC, Liang L, Park JH, Chung CC, Weisenburger DD, Fraumeni JF Jr, Salles G, Glenn M, Cannon-Albright L, Curtin K, Wu X, Smedby KE, de Sanjose S, Skibola CF, Berndt SI, Birmann BM, Chanock SJ, Rothman N (2016). Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Hum Mol Genet, 25(8), 1663-76.
  10. Risk of Incident Colorectal Cancer and Death After Colonoscopy: A Population-based Study in Utah.Samadder NJ, Curtin K, Pappas L, Boucher K, Mineau GP, Smith K, Fraser A, Wan Y, Provenzale D, Kinney AY, Ulrich C, Burt RW (2016). Risk of Incident Colorectal Cancer and Death After Colonoscopy: A Population-based Study in Utah. Clin Gastroenterol Hepatol, 14(2), 279-286.e2.
  11. Familial risk of pediatric chronic rhinosinusitis.Orb Q, Curtin K, Oakley GM, Wong J, Meier J, Orlandi RR, Alt JA (2016). Familial risk of pediatric chronic rhinosinusitis. Laryngoscope, 126(3), 739-45.
  12. Increased Risk of Colorectal Cancer Among Family Members of All Ages, Regardless of Age of Index Case at Diagnosis.Samadder NJ, Smith KR, Hanson H, Pimentel R, Wong J, Boucher K, Ahnen D, Singh H, Ulrich CM, Burt RW, Curtin K (2015). Increased Risk of Colorectal Cancer Among Family Members of All Ages, Regardless of Age of Index Case at Diagnosis. Clin Gastroenterol Hepatol, 13(13), 2305-2311.e2.
  13. Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.Ziv E, Dean E, Hu D, Martino A, Serie D, Curtin K, Campa D, Aftab B, Bracci P, Buda G, Zhao Y, Caswell-Jin J, Diasio R, Dumontet C, Dudzinski M, Fejerman L, Greenberg A, Huntsman S, Jamroziak K, Jurczyszyn A, Kumar S, Atanackovic D, Glenn M, Cannon-Albright LA, Jones B, Lee A, Marques H, Martin T, Martinez-Lopez J, Rajkumar V, Sainz J, Vangsted AJ, Watek M, Wolf J, Slager S, Camp NJ, Canzian F, Vachon C (2015). Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nat Commun, 6, 7539.
  14. Familial risk of chronic rhinosinusitis with and without nasal polyposis: genetics or environment.Oakley GM, Curtin K, Orb Q, Schaefer C, Orlandi RR, Alt JA (2015). Familial risk of chronic rhinosinusitis with and without nasal polyposis: genetics or environment. Int Forum Allergy Rhinol, 5(4), 276-82.
  15. Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database.Lupo PJ, Danysh HE, Plon SE, Curtin K, Malkin D, Hettmer S, Hawkins DS, Skapek SX, Spector LG, Papworth K, Melin B, Erhardt EB, Grufferman S, Schiffman JD (2015). Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database. Cancer Med, 4(5), 781-90.
  16. Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment.Curtin K, Fleckenstein AE, Robison RJ, Crookston MJ, Smith KR, Hanson GR (2015). Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment. Drug Alcohol Depend, 146, 30-8.
  17. Familial colorectal cancer risk by subsite of primary cancer: a population-based study in Utah.Samadder NJ, Smith KR, Mineau GP, Pimentel R, Wong J, Boucher K, Pappas L, Singh H, Ahnen D, Burt RW, Curtin K (2015). Familial colorectal cancer risk by subsite of primary cancer: a population-based study in Utah. Aliment Pharmacol Ther, 41(6), 573-80.
  18. Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB).Venkatramani R, Spector LG, Georgieff M, Tomlinson G, Krailo M, Malogolowkin M, Kohlmann W, Curtin K, Fonstad RK, Schiffman JD (2014). Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB). Am J Med Genet A, 164A(9), 2250-5.
  19. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah.Samadder NJ, Curtin K, Tuohy TM, Rowe KG, Mineau GP, Smith KR, Pimentel R, Wong J, Boucher K, Burt RW (2014). Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah. Gastroenterology, 147(4), 814-821.e5; quiz e15-6.
  20. Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah.Samadder NJ, Curtin K, Wong J, Tuohy TM, Mineau GP, Smith KR, Pimentel R, Pappas L, Boucher K, Garrido-Laguna I, Provenzale D, Burt RW (2014). Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah. Clin Gastroenterol Hepatol, 12(12), 2078-84.e1-2.
  21. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.Samadder NJ, Curtin K, Tuohy TM, Pappas L, Boucher K, Provenzale D, Rowe KG, Mineau GP, Smith K, Pimentel R, Kirchhoff AC, Burt RW (2014). Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Gastroenterology, 146(4), 950-60.
  22. Increased melanoma risk in individuals with papillary thyroid carcinoma.Oakley GM, Curtin K, Layfield L, Jarboe E, Buchmann LO, Hunt JP (2014). Increased melanoma risk in individuals with papillary thyroid carcinoma. JAMA Otolaryngol Head Neck Surg, 140(5), 423-7.
  23. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.Makar KW, Poole EM, Resler AJ, Seufert B, Curtin K, Kleinstein SE, Duggan D, Kulmacz RJ, Hsu L, Whitton J, Carlson CS, Rimorin CF, Caan BJ, Baron JA, Potter JD, Slattery ML, Ulrich CM (2013). COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control, 24(12), 2059-75.
  24. Establishing a familial basis for papillary thyroid carcinoma using the Utah Population Database.Oakley GM, Curtin K, Pimentel R, Buchmann L, Hunt J (2013). Establishing a familial basis for papillary thyroid carcinoma using the Utah Population Database. JAMA Otolaryngol Head Neck Surg, 139(11), 1171-4.
  25. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, Cozen W, Monnereau A, Wang SS, Kelly RS, Lan Q, Teras LR, Chatterjee N, Chung CC, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Armstrong BK, Cocco P, Zhang Y, Severi G, Zeleniuch-Jacquotte A, Lawrence C, Burdette L, Yuenger J, Hutchinson A, Jacobs KB, Call TG, Shanafelt TD, Novak AJ, Kay NE, Liebow M, Wang AH, Smedby KE, Adami HO, Melbye M, Glimelius B, Chang ET, Glenn M, Curtin K, Cannon-Albright LA, Jones B, Diver WR, Link BK, Weiner GJ, Conde L, Bracci PM, Riby J, Holly EA, Smith MT, Jackson RD, Tinker LF, Benavente Y, Becker N, Boffetta P, Brennan P, Foretova L, Maynadie M, McKay J, Staines A, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Lanasa MC, Spector LG, Leis JF, Cunningham JM, Weinberg JB, Morrison VA, Caporaso NE, Norman AD, Linet MS, De Roos AJ, Morton LM, Severson RK, Riboli E, Vineis P, Kaaks R, Trichopoulos D, Masala G, Weiderpass E, Chirlaque MD, Vermeulen RC, Travis RC, Giles GG, Albanes D, Virtamo J, Weinstein S, Clavel J, Zheng T, Holford TR, Offit K, Zelenetz A, Klein RJ, Spinelli JJ, Bertrand KA, Laden F, Giovannucci E, Kraft P, Kricker A, Turner J, Vajdic CM, Ennas MG, Ferri GM, Miligi L, Liang L, Sampson J, Crouch S, Park JH, North KE, Cox A, Snowden JA, Wright J, Carracedo A, Lopez-Otin C, Bea S, Salaverria I, Martin-Garcia D, Campo E, Fraumeni JF Jr, de Sanjose S, Hjalgrim H, Cerhan JR, Chanock SJ, Rothman N, Slager SL (2013). Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet, 45(8), 868-76.
  26. Familial risk of childhood cancer and tumors in the Li-Fraumeni spectrum in the Utah Population Database: implications for genetic evaluation in pediatric practice.Curtin K, Smith KR, Fraser A, Pimentel R, Kohlmann W, Schiffman JD (2013). Familial risk of childhood cancer and tumors in the Li-Fraumeni spectrum in the Utah Population Database: implications for genetic evaluation in pediatric practice. Int J Cancer, 133(10), 2444-53.
  27. Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk.Liu AY, Scherer D, Poole E, Potter JD, Curtin K, Makar K, Slattery ML, Caan BJ, Ulrich CM (2013). Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk. Mol Nutr Food Res, 57(4), 721-34.
  28. Candidate pathway polymorphisms in one-carbon metabolism and risk of rectal tumor mutations.Curtin K, Ulrich CM, Samowitz WS, Wolff RK, Duggan DJ, Makar KW, Caan BJ, Slattery ML (2011). Candidate pathway polymorphisms in one-carbon metabolism and risk of rectal tumor mutations. Int J Mol Epidemiol Genet, 2(1), 1-8.
  29. Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women.Curtin K, Samowitz WS, Ulrich CM, Wolff RK, Herrick JS, Caan BJ, Slattery ML (2011). Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women. Nutr Cancer, 63(3), 357-66.
  30. Exploring multilocus associations of inflammation genes and colorectal cancer risk using hapConstructor.Curtin K, Wolff RK, Herrick JS, Abo R, Slattery ML (2010). Exploring multilocus associations of inflammation genes and colorectal cancer risk using hapConstructor. BMC Med Genet, 11, 170.
  31. Alcohol consumption and rectal tumor mutations and epigenetic changes.Slattery ML, Wolff RK, Herrick JS, Curtin K, Caan BJ, Samowitz W (2010). Alcohol consumption and rectal tumor mutations and epigenetic changes. Dis Colon Rectum, 53(8), 1182-9.
  32. Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes.Slattery ML, Curtin K, Wolff RK, Herrick JS, Caan BJ, Samowitz W (2010). Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes. Cancer Causes Control, 21(8), 1237-45.
  33. Identifying rarer genetic variants for common complex diseases: diseased versus neutral discovery panels.Curtin K, Iles MM, Camp NJ (2009). Identifying rarer genetic variants for common complex diseases: diseased versus neutral discovery panels. Ann Hum Genet, 73(1), 54-60.
  34. Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21.Curtin K, Lin WY, George R, Katory M, Shorto J, Cannon-Albright LA, Bishop DT, Cox A, Camp NJ (2009). Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21. Cancer Epidemiol Biomarkers Prev, 18(2), 616-21.
  35. Somatic alterations, metabolizing genes and smoking in rectal cancer.Curtin K, Samowitz WS, Wolff RK, Herrick J, Caan BJ, Slattery ML (2009). Somatic alterations, metabolizing genes and smoking in rectal cancer. Int J Cancer, 125(1), 158-64.
  36. Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis.Curtin K, Lin WY, George R, Katory M, Shorto J, Cannon-Albright LA, Smith G, Bishop DT, Cox A, Camp NJ (2009). Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis. Cancer Epidemiol Biomarkers Prev, 18(9), 2476-84.
  37. Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer.Curtin K, Samowitz WS, Wolff RK, Ulrich CM, Caan BJ, Potter JD, Slattery ML (2009). Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol Biomarkers Prev, 18(12), 3384-8.
  38. MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer.Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM (2004). MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev, 13(2), 285-92.

Review

  1. Curtin K, Slattery ML, Samowitz WS (2011). CpG island methylation in colorectal cancer: past, present and future. [Review]. Pathology Research International, 902674.

News

Video